Skip to main content

Market Overview

20 Biggest Mid-Day Gainers For Monday

  • Endocyte, Inc. (NASDAQ: ECYT) shares surged 70 percent to $2.39 after the company reported worldwide license of PSMA-617 from ABX GmbH.
  • Capricor Therapeutics Inc (NASDAQ: CAPR) shares gained 33.9 percent to $4.06.
  • VirnetX Holding Corporation (NYSE: VHC) shares jumped 29.5 percent to $5.05 after falling 2.50 percent on Friday.
  • Social Reality Inc (NASDAQ: SRAX) shares climbed 27.6 percent to $3.19 after surging 31.58 percent on Friday. SRAX reported the acquisition of OpenDSP's Demand-Side Platform.
  • Quarterhill Inc (NASDAQ: QTRH) jumped 23.5 percent to $1.63 after the company updated Q3 guidance. The company expects Q3 sales of $72.5 million to $82.5 million and adjusted EBITDA of $50 million to $56 million.
  • Alphatec Holdings Inc (NASDAQ: ATEC) shares gained 23 percent to $2.78. Alphatec named Patrick Miles as Executive Chairman and Quentin Blackford as a member of the Board.
  • Synchronoss Technologies, Inc. (NASDAQ: SNCR) rose 20.6 percent to $11.25 after the company disclosed Friday that it remains in active discussions with multiple parties.
  • Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) jumped 18.5 percent to $3.01 after the company issued an update on FDA review of fostamatinib for ITP. The FDA has indicated it will not hold an Oncology Drugs AdCom meeting for fostamatinib.
  • ITUS Corp (NASDAQ: ITUS) shares gained 14.8 percent to $3.02 after falling 24.86 percent on Friday. ITUS reported the completion of at-the-market offering.
  • Catabasis Pharmaceuticals Inc (NASDAQ: CATB) jumped 14.8 percent to $2.43 after falling 4.93 percent on Friday.
  • Miragen Therapeutics, Inc. (NASDAQ: MGEN) shares rose 14 percent to $10.43.
  • Trinity Industries Inc (NYSE: TRN) shares gained 12.2 percent to $35.77. The U.S. Court Of Appeals for the Fifth Circuit ruled that Trinity Industries did not commit fraud.
  • AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) climbed 11.5 percent to $5.13 after gaining 5.75 percent on Friday.
  • Presbia PLC (NASDAQ: LENS) shares rose 11 percent to $5.00.
  • Veritone Inc (NASDAQ: VERI) shares surged 10.3 percent to $50.15 after climbing 23.24 percent on Friday.
  • Helios and Matheson Analytics Inc (NASDAQ: HMNY) shares gained 7.2 percent to $13.60 after surging 16.74 percent on Friday.
  • Myomo Inc (NYSE: MYO) rose 6.7 percent to $6.40. H.C. Wainwright initiated coverage on Myomo with a Buy rating.
  • Sarepta Therapeutics Inc (NASDAQ: SRPT) gained 6.1 percent to $48.10. Morgan Stanley upgraded Sarepta Therapeutics from Equal-Weight to Overweight.
  • Seattle Genetics, Inc. (NASDAQ: SGEN) rose 4.4 percent to $56.78 as the company disclosed that it has received the FDA Breakthrough Therapy Designation for ADCETRIS in frontline advanced Hodgkin lymphoma.
  • Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) rose 3.5 percent to $121.54. Goldman Sachs upgraded Alnylam Pharmaceuticals from Neutral to Buy.

Related Articles (ALNY + ACRX)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Analyst Ratings Movers

Latest Ratings

CNXB of A SecuritiesDowngrades15.0
ENPHCapital OneDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at